Deguchi, S.; Ogata, F.; Isaka, T.; Otake, H.; Nakazawa, Y.; Kawasaki, N.; Nagai, N.
Prevention of Postprandial Hyperglycemia by Ophthalmic Nanoparticles Based on Protamine Zinc Insulin in the Rabbit. Pharmaceutics 2021, 13, 375.
https://doi.org/10.3390/pharmaceutics13030375
AMA Style
Deguchi S, Ogata F, Isaka T, Otake H, Nakazawa Y, Kawasaki N, Nagai N.
Prevention of Postprandial Hyperglycemia by Ophthalmic Nanoparticles Based on Protamine Zinc Insulin in the Rabbit. Pharmaceutics. 2021; 13(3):375.
https://doi.org/10.3390/pharmaceutics13030375
Chicago/Turabian Style
Deguchi, Saori, Fumihiko Ogata, Takumi Isaka, Hiroko Otake, Yosuke Nakazawa, Naohito Kawasaki, and Noriaki Nagai.
2021. "Prevention of Postprandial Hyperglycemia by Ophthalmic Nanoparticles Based on Protamine Zinc Insulin in the Rabbit" Pharmaceutics 13, no. 3: 375.
https://doi.org/10.3390/pharmaceutics13030375
APA Style
Deguchi, S., Ogata, F., Isaka, T., Otake, H., Nakazawa, Y., Kawasaki, N., & Nagai, N.
(2021). Prevention of Postprandial Hyperglycemia by Ophthalmic Nanoparticles Based on Protamine Zinc Insulin in the Rabbit. Pharmaceutics, 13(3), 375.
https://doi.org/10.3390/pharmaceutics13030375
